ArticleParasites & vectors2025
Vector-borne pathogens in cats and associated fleas in southern Ethiopia.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe worldwide increment of cat populations has increased the risk of ectoparasite infestation and feline vector-borne pathogen (VBP) transmission. In low-income countries, such as Ethiopia, favorable climatic conditions and the absence of preventive measures against ectoparasites contribute to broadening VBP circulation. This study aimed to investigate the prevalence of protozoal (i.e., Hepatozoon, Babesia, and Cytauxzoon species) and bacterial (i.e., Anaplasma, Ehrlichia, Rickettsia, and Bartonella species) infections in owned cats and in their ectoparasites in southern Ethiopia.
methodsThe study was conducted in four districts of the Gamo zone, southern Ethiopia. Cats were sampled, and information about the animals was recorded. Blood samples were collected on Flinders Technology Associates (FTA) cards, while ectoparasites were collected by combing and stored in 70% ethanol. Fleas were morphologically identified, and DNA was extracted from both blood samples and ectoparasites, then submitted to molecular analysis. Real-time polymerase chain reaction (PCR) and end-point PCR were used to detect pathogens. Positive samples were sequenced, and a phylogenetic analysis was performed on the obtained Hepatozoon spp. and Rickettsia spp. sequences.
resultsOverall, 109 cats were sampled, and 115 fleas (i.e., 28 Ctenocephalides felis and 87 Echidnophaga gallinacea) and three ticks (Haemaphysalis laechi) were collected. Molecular analysis of feline blood samples revealed Hepatozoon spp. as the most common pathogen (36.7%; CI:28.3-46.1%), followed by Rickettsia spp. (5.5%; CI: 2.5-11.5%), Bartonella spp. (2.8%; CI:0.9-7.8%), and Babesia spp. (0.9%; CI:0.2-5.0%); whereas fleas harbored mostly Rickettsia spp. (52.2%; CI:43.1-61.1%), followed by Bartonella spp. (6.1%; CI: 3.0-12.0%), and Hepatozoon spp. (0.9%; CI: 0.2-4.8%). According to phylogenetic clustering, specimens of the Hepatozoon genus were classified as H. felis, H. luiperdjie,, and H. canis. Concerning the genus Rickettsia, it was not possible to reach a clear identification for the majority of the sequences, apart from some specimens ascribable to R. felis and R. asembonensis.
conclusionsVector-borne pathogens posing significant threats to animal and human health were detected in this study. Molecular analysis suggested the circulation of different and genetically variable species in the feline host. The molecular approach allowed the identification of VBPs in the cat population and their fleas, providing new data on their occurrence and prevalence in Ethiopia and, more generally, in sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.